-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Pharmacological intervention
-
Immunomodulator
-
Prednisolone
-
Vitamin B1
-
Vitamin B12
-
Vitamin B6
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Plasma exchange
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Blood sample
-
Stool sample
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
Fragile population
-
Immunocompromised host
-
SARS-CoV-2
-
Post COVID-19 condition
-
Pharmacological intervention
-
Monoclonal antibodies
-
AZD3152/Sipavibart